title: Effects of leukaemia inhibitory factor on embryo implantation in the mouse.
abstract: Leukaemia inhibitory factor (LIF) is a pleiotrophic cytokine. Recent reports indicate that LIF is relevant to murine embryo implantation. In this work, results of indirect immunofluorescence under a confocal microscope illustrated that LIF was mainly located in the uterine lumen and uterine epithelial cells in pregnant mice on day 4. The number of embryos implanted in pregnant mice on day 8 decreased significantly after injection of 3 microg LIF antibodies into a uterine horn (P<0.001), which demonstrated again that LIF is a critical factor for embryo implantation. In a co-culture system, LIF (0.1 ng/ml, 1 ng/ml, 10 ng/ml and 100 ng/ml) significantly enhanced the blastocyst outgrowth after 24, 48 or 72 h of co-culture, and outgrowth areas after 72 h of co-culture. Conversely, 5 microg/ml and 10 microg/ml, but not 1 microg/ml, LIF antibodies decreased the percentage of blastocysts with outgrowth; only 10 microg/ml LIF antibody inhibited blastocyst outgrowth area significantly (P<0.001). However, neither LIF nor its antibodies changed embryo attachment. Analysis of correlation showed that the effects of LIF or its antibodies on the blastocyst outgrowth were dose-dependent. In summary, different pathways may exist to regulate the blastocyst attachment and outgrowth on a monolayer of uterine epithelial cells. LIF protein from the maternal uterus exerts an essential role in embryo implantation in the mouse, which is mediated by stimulating trophoblast outgrowth, but not by promoting the attachment.
authors.affiliation: State Key Laboratory of Reproductive Biology, Institute of Zoology, Academia Sinica, Beijing, P. R. China.
authors.forename: L Q
authors.initials: LQ
authors.lastname: Cai
authors.forename: Y J
authors.initials: YJ
authors.lastname: Cao
authors.forename: E K
authors.initials: EK
authors.lastname: Duan
mesh_terms: D000818:Animals; D001755:Blastocyst / Q000378:metabolism; D018920:Coculture Techniques; D010064:Embryo Implantation / Q000187:drug effects / Q000502:physiology*; D005260:Female; D019084:Fluorescent Antibody Technique, Indirect; D006131:Growth Inhibitors / Q000494:pharmacology* / Q000502:physiology*; D015850:Interleukin-6; D053605:Leukemia Inhibitory Factor; D008222:Lymphokines / Q000494:pharmacology* / Q000502:physiology*; D051379:Mice; D018613:Microscopy, Confocal; D011247:Pregnancy; D011270:Pregnancy, Animal; D011994:Recombinant Proteins / Q000378:metabolism; D013997:Time Factors; D014599:Uterus / Q000378:metabolism
chemical_list: D006131:Growth Inhibitors; D015850:Interleukin-6; D053605:Leukemia Inhibitory Factor; C507838:Lif protein, mouse; D008222:Lymphokines; D011994:Recombinant Proteins